Medical News

RSS

Researchers develop new method for producing image of individual DNA molecules' genetic make-up

A completely new method for producing an image of individual DNA molecules' genetic make-up has been developed by researchers in Sweden and Denmark. The results are published in the latest issue of the journal Proceedings of the National Academy of Sciences of the USA (PNAS).

19 Jul 2010

U.S. District Court upholds validity of Nycomed's Protonix patent

Nycomed announced today that Judge Jose L. Linares of the U.S. District Court for the District of New Jersey has confirmed the jury verdict in favor of Nycomed and Pfizer Inc. The decision upholds the jury verdict issued on April 23, 2010, confirming that the patent is valid and rejecting allegations by the defendants that the patent was invalid as obvious and invalid for double patenting. Against KUDCo, the US generic drug business of the Schwarz Pharma Group, which did not at-risk launch, final Judgment was entered as a result of Judge Jose L. Linares' rulings.

19 Jul 2010

Visage Imaging releases Amira 5.3 single platform brain imaging tool

Visage Imaging®, Inc., a wholly owned subsidiary of Pro Medicus Ltd., is pleased to announce the immediate release of Amira 5.3, a new major version of its market-leading software platform for visualizing, analyzing, and presenting complex 3D and 4D biomedical data.

19 Jul 2010

Novo Nordisk recruits 60,000th patient in world's largest observational study in insulin therapy

Today, Novo Nordisk announced the landmark recruitment of the 60,000th patient in the A1chieve(R) study - an observational study designed to investigate the effects of modern insulins in the management of type 2 diabetes.

From Novo Nordisk 19 Jul 2010

Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference

Genetic Immunity, a US/Hungarian biopharmaceutical company developing nanomedicine-based immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data on the Company's novel DermaVir therapeutic vaccine for HIV/AIDS during the XVIII International AIDS Conference this week in Vienna, Austria. DermaVir, the first dendritic cell-targeting topical HIV vaccine candidate, employs nanotechnology to induce multi-faceted and long-lived immune responses capable of eliminating HIV infected cells.

19 Jul 2010

ViroStatics to present VS411 Phase II dose-ranging trial data at International AIDS Conference in Vienna

ViroStatics, a US/Italian biopharmaceutical company developing innovative immunotherapies for HIV/AIDS and other chronic diseases, is releasing Phase II data from a randomized, dose-ranging trial of VS411, the Company's novel combination product for treating HIV/AIDS, during the XVII International AIDS Conference this week in Vienna, Austria.

19 Jul 2010

FIT Biotech to present results of FIT-06 Phase II clinical trial at XVIII International AIDS 2010 Conference

FIT Biotech, a privately held biotechnology company developing novel, proprietary immunotherapies for HIV/AIDS and other viral diseases, announced results today from a Phase II clinical trial. The company's immunomodulator FIT-06 showed unprecedented long-term reductions in viral load (approximately 0.5 log) and statistically significant CD4 cell count increases in HIV-infected, previously untreated patients. The effect lasted longer than two years in the absence of any anti-retroviral therapy.

19 Jul 2010

Study evaluates immunization benefits of dissolving microneedles

A new vaccine-delivery patch based on hundreds of microscopic needles that dissolve into the skin could allow persons without medical training to painlessly administer vaccines - while providing improved immunization against diseases such as influenza.

19 Jul 2010

Three different methods for accurately measuring breast density

Two new studies announced this week have tested three different methods for accurately measuring breast density -- the relative portion of tissue to fat in a woman's breasts and a strong indicator of breast cancer risk.

19 Jul 2010

Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research

A pneumococcal conjugate vaccine introduced in the U.S. 10 years ago appears to reduce pneumonia and serious associated complications, such as blood infections, in the vaccine's target range, children less than a year old, according to new research.

19 Jul 2010

Over-expression of CIB1 protein triggers biochemical processes that lead to cardiac hypertrophy: Study

Scientists have identified a key molecular regulator of cardiac hypertrophy (enlargement of the heart) that may provide a therapeutic target for a major risk factor of heart failure and early death.

19 Jul 2010

Brain cancer survivor completes journey across America to raise awareness, money for brain cancer research

Anne Feeley, a 56-year-old mother and brain cancer survivor, completed her journey across America today, cycling 3,708 miles, to raise awareness and money for brain cancer research and patient care. Feeley pedaled the last 6.5 miles of her journey from Hains Point, VA to cross the finish line at the Capital Reflecting Pool in Washington, DC.

19 Jul 2010

Sen. Roberts lashes out at recess appointment of Berwick

"Kansas Sen. Pat Roberts is taking aim at President Barack Obama for making a recess appointment of Dr. Donald Berwick as the new head of the federal agency overseeing Medicare and Medicaid," CNN reported.

19 Jul 2010

Tet 1 protein helps stem cells renew themselves and stay pluripotent: Researchers

Take a skin cell from a patient with Type 1 diabetes. Strip out everything that made it a skin cell, then reprogram it to grow into a colony of pancreatic beta cells. Implant these into your patient and voilà! She's producing her own insulin like a pro.

19 Jul 2010

Olig1 and Olig2 genes are associated with Down syndrome, scientists identify

Down syndrome is a well known cause of mental retardation and other medical problems, including early onset of Alzheimer disease. It has long been known that Down syndrome is associated with an individual having an additional copy of chromosome 21. Research findings reported in the July 18 advanced online publication of Nature Neuroscience have narrowed down the critical genetic elements responsible for some aspects of Down syndrome.

19 Jul 2010

Businesses, states seek solutions to rising health insurance costs

News outlets, including The New York Times, reported on health insurance in light of the new law: "the country's biggest insurers are promoting affordable plans with reduced premiums that require participants to use a narrower selection of doctors or hospitals.

19 Jul 2010

Effective AIDS treatment but poor accessibility: Report from International AIDS conference 2010

At the 18th AIDS conference 2010 in Vienna, Julio Montaner — the President of the International AIDS Society and Chairman of the AIDS 2010 conference said this Sunday that the G-8 countries were not doing enough to ensure treatment of all people infected with HIV and AIDS. He said, “This is a very serious deficit… Let's rejoice in the fact that today we have treatments that work ... what we need is the political will to go the extra mile to deliver universal access.”

18 Jul 2010

Cash incentives cut down HIV transmission: World Bank Studies

A cash incentive has been found to lower the rates of HIV and sexually transmitted disease transmission among Malawian and Tanzanian youths revealed the World Bank, this Sunday. There were two studies undertaken to make this connection.

18 Jul 2010

Artificial colours in food linked to cancer and behavioral disorders in children: Study

Artificial colours in foods, scientists have found may increase the risk of getting cancer, allergies and may trigger hyperactivity in susceptible children. This new report entitled, “Food Dyes: A Rainbow of Risks”, has come from the research conducted by the Centre for Science in the Public Interest (CSPI).

18 Jul 2010

Center for Regulatory Effectiveness concerned over undue influence by agency on tobacco advisory panel

The watchdog group Center for Regulatory Effectiveness (CRE) today urged the Commissioner of the Food and Drug Administration (FDA) to assure that advice provided by a tobacco advisory committee on menthol cigarettes is "independent and not influenced by agency staff" in accordance with federal law.

17 Jul 2010

Medical News

Researchers develop new method for producing image of individual DNA molecules' genetic make-up

U.S. District Court upholds validity of Nycomed's Protonix patent

Visage Imaging releases Amira 5.3 single platform brain imaging tool

Novo Nordisk recruits 60,000th patient in world's largest observational study in insulin therapy

Phase II data on Genetic Immunity's DermaVir vaccine to be presented at XVIII International AIDS Conference

ViroStatics to present VS411 Phase II dose-ranging trial data at International AIDS Conference in Vienna

FIT Biotech to present results of FIT-06 Phase II clinical trial at XVIII International AIDS 2010 Conference

Study evaluates immunization benefits of dissolving microneedles

Three different methods for accurately measuring breast density

Pneumococcal conjugate vaccine appears to reduce pneumonia, serious complications in infants: Research

Over-expression of CIB1 protein triggers biochemical processes that lead to cardiac hypertrophy: Study

Brain cancer survivor completes journey across America to raise awareness, money for brain cancer research

Sen. Roberts lashes out at recess appointment of Berwick

Tet 1 protein helps stem cells renew themselves and stay pluripotent: Researchers

Olig1 and Olig2 genes are associated with Down syndrome, scientists identify

Businesses, states seek solutions to rising health insurance costs

Effective AIDS treatment but poor accessibility: Report from International AIDS conference 2010

Cash incentives cut down HIV transmission: World Bank Studies

Artificial colours in food linked to cancer and behavioral disorders in children: Study

Center for Regulatory Effectiveness concerned over undue influence by agency on tobacco advisory panel

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

How GLP‑1 Agonists Are Shaping the Future of Obesity Treatment With Dr Bryony Henderson

Flow chemistry, AI, and NMR: A next-gen approach to scalable API production

Latest News